The present disclosure provides compounds suitable for inhibiting CaMKK2. Also provided are compositions and methods of treating diseases associated with CaMKK2.
本公开提供适用于抑制CaMKK2的化合物。还提供了与CaMKK2相关疾病的治疗方法和组合物。
Cobalt‐Catalyzed Enantioselective Hydroamination of Arylalkenes with Secondary Amines
An excellent enantioselective hydroamination of arylalkenes with Lewis basic secondary amines was developed, via an elegant cobalt-hydride mediated oxidative hydrogen atom transfer (MHAT) process, leading to the synthesis of a series of valuable α-chiral tertiary amines in good to excellent yields and enantioselectivities.
The development of catalytic asymmetric radical reactions is an attractive but formidable task. The high reactivity of radicals enables the use of readily accessible feedstocks and mild reaction conditions, but it leads to substantial difficulty for chiral catalysts to provide sufficient enantiocontrol. Moreover, a racemic background process is often inevitable, further deteriorating enantioselectivity
The present disclosure provides compounds suitable for inhibiting CaMKK2. Also provided are compositions and methods of treating diseases associated with CaMKK2.